JP2010502629A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502629A5 JP2010502629A5 JP2009526788A JP2009526788A JP2010502629A5 JP 2010502629 A5 JP2010502629 A5 JP 2010502629A5 JP 2009526788 A JP2009526788 A JP 2009526788A JP 2009526788 A JP2009526788 A JP 2009526788A JP 2010502629 A5 JP2010502629 A5 JP 2010502629A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bolus
- total dose
- human
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82386806P | 2006-08-29 | 2006-08-29 | |
| US60/823,868 | 2006-08-29 | ||
| PCT/US2007/074997 WO2008027687A2 (en) | 2006-08-29 | 2007-08-01 | Use of tenecteplase for treating acute ischemic stroke |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010502629A JP2010502629A (ja) | 2010-01-28 |
| JP2010502629A5 true JP2010502629A5 (https=) | 2011-08-18 |
| JP5785687B2 JP5785687B2 (ja) | 2015-09-30 |
Family
ID=38835003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009526788A Active JP5785687B2 (ja) | 2006-08-29 | 2007-08-01 | 急性虚血性脳卒中を処置するためのテネクテプラーゼの使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20080107641A1 (https=) |
| EP (1) | EP2056856B1 (https=) |
| JP (1) | JP5785687B2 (https=) |
| KR (1) | KR20090045405A (https=) |
| CN (1) | CN101505785A (https=) |
| AU (1) | AU2007290277B2 (https=) |
| BR (1) | BRPI0716143A2 (https=) |
| CA (1) | CA2661012C (https=) |
| CO (1) | CO6150188A2 (https=) |
| EA (1) | EA015573B1 (https=) |
| EC (1) | ECSP099178A (https=) |
| IL (2) | IL196987A (https=) |
| MX (1) | MX2009001918A (https=) |
| MY (1) | MY163119A (https=) |
| NO (1) | NO342302B1 (https=) |
| NZ (1) | NZ574767A (https=) |
| SG (3) | SG10201804944XA (https=) |
| TW (1) | TWI439282B (https=) |
| UA (1) | UA97486C2 (https=) |
| WO (1) | WO2008027687A2 (https=) |
| ZA (1) | ZA200900957B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| EP2540696B1 (en) | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
| BRPI0716143A2 (pt) | 2006-08-29 | 2013-11-26 | Genentech Inc | Uso de tenecteplase para tratar derrame isquêmico agudo |
| CN101687757A (zh) | 2007-04-13 | 2010-03-31 | 扩散药品有限公司 | 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用 |
| US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
| US20110257510A1 (en) * | 2008-12-24 | 2011-10-20 | Koninklijke Philips Electronics N.V. | System, method and apparatus for cardiac intervention with mr stroke detection and treatment |
| EP2445339B1 (en) * | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
| EP2470015B1 (en) * | 2009-08-24 | 2016-01-13 | Hough Ear Institute | Nitrone compounds for treating sensorineural hearing loss |
| AU2011262361A1 (en) | 2010-06-02 | 2013-01-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
| JP6375112B2 (ja) * | 2010-12-23 | 2018-08-15 | ジェノヴァ バイオファーマシューティカルズ リミテッド | テネクテプラーゼの医薬組成物 |
| WO2014062888A1 (en) * | 2012-10-18 | 2014-04-24 | University Of South Florida | Compositions and methods for treating stroke |
| US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
| US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
| CA2901443A1 (en) | 2013-03-15 | 2014-09-25 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
| US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
| WO2015023830A1 (en) | 2013-08-14 | 2015-02-19 | Stc.Unm | Treatment and prevention of stroke and other neurological disorders |
| PL3209767T3 (pl) * | 2014-10-21 | 2021-01-11 | Gennova Biopharmaceuticals Ltd. | Nowy sposób oczyszczania do izolacji i komercyjnej produkcji zrekombinowanego tnk-tpa (tenekteplazy) |
| EP3416568A4 (en) | 2016-02-16 | 2019-10-16 | Insera Therapeutics, Inc. | SUCTION DEVICES AND ANCHORED FLOW REVERSING DEVICES |
| CA3018550A1 (en) | 2016-03-24 | 2017-09-28 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| EP3936140B1 (en) * | 2017-01-24 | 2023-08-30 | Boston Scientific Scimed, Inc. | Thrombolytic agent for the treatment of thromboembolism |
| EP3624832B1 (en) * | 2017-05-16 | 2025-08-20 | Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for the treatment of acute ischemic stroke |
| US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
| US20230068460A1 (en) * | 2020-02-04 | 2023-03-02 | The Regents Of The University Of Colorado, A Body Corporate | Prophylactic uses of annexin a2 |
| IL295727A (en) * | 2020-02-19 | 2022-10-01 | Nono Inc | Combined treatment of stroke with a plasmin-degradable and reperfusion psd-95 inhibitor |
| CN114984197A (zh) * | 2022-07-01 | 2022-09-02 | 江苏丰华生物制药有限公司 | 替奈普酶在制备用于治疗急性缺血性卒中的药物组合物中的应用 |
| CN115487294A (zh) * | 2022-07-12 | 2022-12-20 | 上海丰华天力通生物医药有限公司 | 替奈普酶在制备用于治疗轻型缺血性卒中的药物组合物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| ATE155816T1 (de) | 1992-06-03 | 1997-08-15 | Genentech Inc | Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung |
| JP2002173447A (ja) * | 2000-09-29 | 2002-06-21 | Yamanouchi Pharmaceut Co Ltd | 脳塞栓症治療用医薬組成物 |
| US7084118B2 (en) * | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
| US20030180282A1 (en) * | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
| US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
| WO2006094120A2 (en) * | 2005-03-02 | 2006-09-08 | The Regents Of The University Of California | Treatment for embolic stroke |
| BRPI0716143A2 (pt) | 2006-08-29 | 2013-11-26 | Genentech Inc | Uso de tenecteplase para tratar derrame isquêmico agudo |
-
2007
- 2007-08-01 BR BRPI0716143-3A patent/BRPI0716143A2/pt not_active Application Discontinuation
- 2007-08-01 AU AU2007290277A patent/AU2007290277B2/en active Active
- 2007-08-01 KR KR1020097006363A patent/KR20090045405A/ko not_active Ceased
- 2007-08-01 EA EA200970237A patent/EA015573B1/ru unknown
- 2007-08-01 SG SG10201804944XA patent/SG10201804944XA/en unknown
- 2007-08-01 TW TW096128284A patent/TWI439282B/zh active
- 2007-08-01 CA CA2661012A patent/CA2661012C/en not_active Expired - Fee Related
- 2007-08-01 ZA ZA200900957A patent/ZA200900957B/xx unknown
- 2007-08-01 JP JP2009526788A patent/JP5785687B2/ja active Active
- 2007-08-01 NZ NZ574767A patent/NZ574767A/en unknown
- 2007-08-01 MY MYPI20090793A patent/MY163119A/en unknown
- 2007-08-01 WO PCT/US2007/074997 patent/WO2008027687A2/en not_active Ceased
- 2007-08-01 US US11/832,291 patent/US20080107641A1/en not_active Abandoned
- 2007-08-01 CN CNA2007800318116A patent/CN101505785A/zh active Pending
- 2007-08-01 SG SG10201501498VA patent/SG10201501498VA/en unknown
- 2007-08-01 MX MX2009001918A patent/MX2009001918A/es active IP Right Grant
- 2007-08-01 UA UAA200902855A patent/UA97486C2/ru unknown
- 2007-08-01 SG SG2011062213A patent/SG174753A1/en unknown
- 2007-08-01 EP EP07840638.6A patent/EP2056856B1/en active Active
-
2009
- 2009-02-09 IL IL196987A patent/IL196987A/en active IP Right Grant
- 2009-02-27 CO CO09020350A patent/CO6150188A2/es unknown
- 2009-03-12 EC EC2009009178A patent/ECSP099178A/es unknown
- 2009-03-27 NO NO20091296A patent/NO342302B1/no unknown
-
2011
- 2011-07-22 US US13/189,413 patent/US9023346B2/en active Active
-
2016
- 2016-10-05 IL IL248176A patent/IL248176A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010502629A5 (https=) | ||
| JP2018500332A5 (https=) | ||
| JP2018506550A5 (https=) | ||
| JP2018510132A5 (https=) | ||
| JP2022186932A (ja) | Ｎｔｃｐ阻害剤によるアテローム性動脈硬化、原発性胆汁性肝硬変およびｎｒｌｐ３インフラマソーム関連疾患の治療 | |
| JP2015525798A5 (https=) | ||
| JP2010222367A5 (https=) | ||
| PE20091184A1 (es) | Formas de dosificacion farmaceutica | |
| FI3227675T3 (fi) | Aktiviini-actrii-antagonisteja ja niiden käyttöjä myelodysplastisen oireyhtymän hoitamiseksi | |
| WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
| WO2006039704A3 (en) | Pharmaceutical composition and method for treating a joint capsule arthropathy | |
| JP2015500887A5 (https=) | ||
| NZ588913A (en) | Liver cancer drug | |
| NZ599558A (en) | Dosing regimen associated with long-acting injectable paliperidone esters | |
| JP2016514132A5 (https=) | ||
| WO2010065950A3 (en) | Albumin binding peptide-mediated disease targeting | |
| JP2019508433A5 (https=) | ||
| WO2008144269A3 (en) | Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| BRPI0921097A2 (pt) | composto derivado de pirazol-3 carboxamida com atividade de antagonista de receptor 5-ht2b, agente preventivo ou terapêutico, composição farmacêutica e uso do composto ou seu sal farmaceuticamente aceitável e método ou prevenção ou tratamento. | |
| WO2018075901A8 (en) | Methods of delivering a neuroprotective polypeptide to the central nervous system | |
| JP2017503014A5 (https=) | ||
| JP2020523384A5 (https=) | ||
| JP2020524670A5 (https=) | ||
| HRP20201632T1 (hr) | Režimi doziranja melflufena kod raka |